245 related articles for article (PubMed ID: 36467781)
1.
Viana MB; de Aquino PEA; Estadella D; Ribeiro DA; Viana GSB
Med Cannabis Cannabinoids; 2022; 5(1):207-219. PubMed ID: 36467781
[TBL] [Abstract][Full Text] [Related]
2. Cannabidiol for neurodegenerative disorders: A comprehensive review.
Bhunia S; Kolishetti N; Arias AY; Vashist A; Nair M
Front Pharmacol; 2022; 13():989717. PubMed ID: 36386183
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective potential of cannabidiol: Molecular mechanisms and clinical implications.
Tambe SM; Mali S; Amin PD; Oliveira M
J Integr Med; 2023 May; 21(3):236-244. PubMed ID: 36973157
[TBL] [Abstract][Full Text] [Related]
4. Current Aspects of the Endocannabinoid System and Targeted THC and CBD Phytocannabinoids as Potential Therapeutics for Parkinson's and Alzheimer's Diseases: a Review.
Cooray R; Gupta V; Suphioglu C
Mol Neurobiol; 2020 Nov; 57(11):4878-4890. PubMed ID: 32813239
[TBL] [Abstract][Full Text] [Related]
5. Modulation of Oxidative Stress and Neuroinflammation by Cannabidiol (CBD): Promising Targets for the Treatment of Alzheimer's Disease.
Hickey JP; Collins AE; Nelson ML; Chen H; Kalisch BE
Curr Issues Mol Biol; 2024 May; 46(5):4379-4402. PubMed ID: 38785534
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic Prospects of Cannabinoids in the Immunomodulation of Prevalent Autoimmune Diseases.
Rodríguez Mesa XM; Moreno Vergara AF; Contreras Bolaños LA; Guevara Moriones N; Mejía Piñeros AL; Santander González SP
Cannabis Cannabinoid Res; 2021 Jun; 6(3):196-210. PubMed ID: 34030476
[No Abstract] [Full Text] [Related]
7. Cannabidiol goes nuclear: The role of PPARγ.
Khosropoor S; Alavi MS; Etemad L; Roohbakhsh A
Phytomedicine; 2023 Jun; 114():154771. PubMed ID: 36965374
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoids in Treating Parkinson's Disease Symptoms: A Systematic Review of Clinical Studies.
Varshney K; Patel A; Ansari S; Shet P; Panag SS
Cannabis Cannabinoid Res; 2023 Oct; 8(5):716-730. PubMed ID: 37253174
[No Abstract] [Full Text] [Related]
9. Cannabinoids in Late Life Parkinson's Disease and Dementia: Biological Pathways and Clinical Challenges.
Costa AC; Joaquim HPG; Pedrazzi JFC; Pain AO; Duque G; Aprahamian I
Brain Sci; 2022 Nov; 12(12):. PubMed ID: 36552056
[TBL] [Abstract][Full Text] [Related]
10. Cannabinoids and Schizophrenia: Risks and Therapeutic Potential.
Manseau MW; Goff DC
Neurotherapeutics; 2015 Oct; 12(4):816-24. PubMed ID: 26311150
[TBL] [Abstract][Full Text] [Related]
11. Cannabidiol in Neurological and Neoplastic Diseases: Latest Developments on the Molecular Mechanism of Action.
Ożarowski M; Karpiński TM; Zielińska A; Souto EB; Wielgus K
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919010
[TBL] [Abstract][Full Text] [Related]
12. Anti-Cancer and Anti-Proliferative Potential of Cannabidiol: A Cellular and Molecular Perspective.
Mashabela MD; Kappo AP
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891847
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic potential of cannabidiol (CBD) in the treatment of cardiovascular diseases.
Naya NM; Kelly J; Hogwood A; Abbate A; Toldo S
Expert Opin Investig Drugs; 2024 May; ():. PubMed ID: 38703078
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of cannabis constituents on schizophrenia-related psychosis: a rationale for incorporating cannabidiol into a schizophrenia therapeutic regimen.
Johnson K; Weldon AJ; Burmeister MA
Front Psychiatry; 2024; 15():1386263. PubMed ID: 38716117
[TBL] [Abstract][Full Text] [Related]
15. Assessing Cannabidiol as a Therapeutic Agent for Preventing and Alleviating Alzheimer's Disease Neurodegeneration.
Chen L; Sun Y; Li J; Liu S; Ding H; Wang G; Li X
Cells; 2023 Nov; 12(23):. PubMed ID: 38067101
[TBL] [Abstract][Full Text] [Related]
16. Cannabidiol-from Plant to Human Body: A Promising Bioactive Molecule with Multi-Target Effects in Cancer.
Kis B; Ifrim FC; Buda V; Avram S; Pavel IZ; Antal D; Paunescu V; Dehelean CA; Ardelean F; Diaconeasa Z; Soica C; Danciu C
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31775230
[No Abstract] [Full Text] [Related]
17. The Role of Cannabidiol in Liver Disease: A Systemic Review.
Chen S; Kim JK
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397045
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective Effect of a Pharmaceutical Extract of Cannabis with High Content on CBD Against Rotenone in Primary Cerebellar Granule Cell Cultures and the Relevance of Formulations.
Echeverry C; Richeri A; Fagetti J; Martínez GF; Vignolo F; Prunell G; Cuñetti L; Martínez Busi M; Pérez S; de Medina VS; Ferreiro C; Scorza C
Cannabis Cannabinoid Res; 2024 Jun; 9(3):e907-e916. PubMed ID: 37155642
[No Abstract] [Full Text] [Related]
19. Beyond Pain Relief: A Review on Cannabidiol Potential in Medical Therapies.
Luz-Veiga M; Azevedo-Silva J; Fernandes JC
Pharmaceuticals (Basel); 2023 Jan; 16(2):. PubMed ID: 37259306
[TBL] [Abstract][Full Text] [Related]
20. Alzheimer's disease, aging, and cannabidiol treatment: a promising path to promote brain health and delay aging.
Liu Y
Mol Biol Rep; 2024 Jan; 51(1):121. PubMed ID: 38227160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
